Immunovia AB (IMMNOV):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Immunovia AB (IMMNOV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8274
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease progression, and monitoring the therapeutic responsiveness of cancers. Immunovia’s IMMray can also be used for biomarker discovery through its discovery tool for proteome scanning. The company also provides IMMray PanCan-d, a blood-based test for the detection of pancreatic cancer. Its therapeutic areas include cancer and autoimmune diseases such as systemic lupus erythematosus. The company collaborates with various cancer centers for conducting clinical evidence studies. Immunovia is headquartered in Lund, Sweden.

Immunovia AB (IMMNOV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Immunovia AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Immunovia AB, Medical Devices Deals, 2012 to YTD 2018 9
Immunovia AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Immunovia AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Immunovia Enters into Agreement with University of Pittsburgh 11
Immunovia Enters into Research Collaboration Agreement with Linkoping University 12
Immunovia to Enter into Agreement with National Cancer Institute 13
Immunovia Enters into Agreement with University of Liverpool 14
Immunovia Partners with OHSU Knight Cancer Institute 15
Equity Offering 16
Immunovia Raises USD37.3 Million in Private Placement of Shares 16
Immunovia Raises USD3.4 Million in Rights Offering of Shares 18
Immunovia Prices Private Placement of Shares for USD22.3 Million 20
Immunovia Plans to Raise Funds in Public Offering of Shares 21
Immunovia Raises USD7 Million in IPO 22
Immunovia AB – Key Competitors 23
Immunovia AB – Key Employees 24
Immunovia AB – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 24, 2018: Immunovia interim report, january-june 2018 26
Apr 27, 2018: Immunovia Interim report, January-March 2018 27
Feb 15, 2018: Immunovia Full Year report, January-December 2017 28
Nov 10, 2017: Immunovia Interim report, January-September 2017 29
Aug 23, 2017: Immunovia Interim report January-June 2017 30
Apr 20, 2017: Immunovia Interim report, January-March 2017 31
Feb 15, 2017: Immunovia Financial Statement 2016 32
Corporate Communications 33
Jul 17, 2017: Leading pancreatic cancer expert on early symptoms Professor Stephen Pereira at University College London joins Immunovia’s Scientific Advisory Board 33
Other Significant Developments 34
Jun 28, 2017: Immunovia Establishes US Headquarters, Including CLIA Reference Laboratory, in Boston 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Immunovia AB, Pharmaceuticals & Healthcare, Key Facts 2
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Immunovia AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Immunovia AB, Deals By Therapy Area, 2012 to YTD 2018 8
Immunovia AB, Medical Devices Deals, 2012 to YTD 2018 9
Immunovia AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Immunovia Enters into Agreement with University of Pittsburgh 11
Immunovia Enters into Research Collaboration Agreement with Linkoping University 12
Immunovia to Enter into Agreement with National Cancer Institute 13
Immunovia Enters into Agreement with University of Liverpool 14
Immunovia Partners with OHSU Knight Cancer Institute 15
Immunovia Raises USD37.3 Million in Private Placement of Shares 16
Immunovia Raises USD3.4 Million in Rights Offering of Shares 18
Immunovia Prices Private Placement of Shares for USD22.3 Million 20
Immunovia Plans to Raise Funds in Public Offering of Shares 21
Immunovia Raises USD7 Million in IPO 22
Immunovia AB, Key Competitors 23
Immunovia AB, Key Employees 24
Immunovia AB, Subsidiaries 25

List of Figures
Immunovia AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Immunovia AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Immunovia AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Immunovia AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Immunovia AB (IMMNOV):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cosmo Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Cosmo Oil Co Ltd (Cosmo Oil), a subsidiary of Cosmo Energy Holdings Co Ltd, procures oil and refines, distributes, imports and exports petroleum products and petrochemical products. The company operates Chiba, Yokkaichi and Sakai refineries. These refineries produce petroleum products such a …
  • Principal Financial Group Inc.:企業のM&A・事業提携・投資動向
    Principal Financial Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Principal Financial Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Caixa Economica Federal:企業の戦略・SWOT・財務分析
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Basellandschaftliche Kantonalbank:企業の戦略・SWOT・財務分析
    Basellandschaftliche Kantonalbank - Strategy, SWOT and Corporate Finance Report Summary Basellandschaftliche Kantonalbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Japan Pulp and Paper Company Limited:企業の戦略・SWOT・財務分析
    Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • IP Group Plc (IPO):企業の財務・戦略的SWOT分析
    Summary IP Group Plc (IP Group) is a provider of venture capital, business building and support, networks and recruitment services. The company invests in companies, which comprise early stage to mature businesses from various sectors such as energy and renewables, medical equipment and supplies, ph …
  • United Breweries Limited:企業の戦略・SWOT・財務情報
    United Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary United Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Inovio Pharmaceuticals Inc (INO)-医療機器分野:企業M&A・提携分析
    Summary Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA vaccines (immunotherapies) for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology a …
  • APRIL Group S.A. (APR):企業の財務・戦略的SWOT分析
    APRIL Group S.A. (APR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ggp Inc:企業の戦略・SWOT・財務分析
    Ggp Inc - Strategy, SWOT and Corporate Finance Report Summary Ggp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • BGFIBank Group:企業の戦略・SWOT・財務分析
    BGFIBank Group - Strategy, SWOT and Corporate Finance Report Summary BGFIBank Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The New Zealand Refining Co Ltd (NZR):石油・ガス:M&Aディール及び事業提携情報
    Summary The New Zealand Refining Co Ltd. (Refining NZ) is an oil refining company that refines and distributes oil products. It operates an oil refinery at Marsden Point in Whangarei, New Zealand. The company processes crude oil types imported from offshore markets and produces refined petroleum pro …
  • Bilfinger SE (GBF)-エネルギー分野:企業M&A・提携分析
    Summary Bilfinger SE (Bilfinger) is one of the leading global engineering and services companies in the world. It offers a wide range of design, construction, maintenance, engineering, consulting, and project management services across diverse end markets. The company’s major service offerings inclu …
  • OmniGuide Inc:医療機器:M&Aディール及び事業提携情報
    Summary OmniGuide Inc (OmniGuide) is a medical device company that offers microsurgery, laparoscopy, and robotic assisted surgery products. The company’s products comprise GYN systems, ENT systems, OTO systems, line of sight systems, robotic surgical products and others. It also offers gynecology su …
  • Just the Berries Ltd:企業の戦略・SWOT・財務情報
    Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report Summary Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bucher Industries AG:企業の戦略・SWOT・財務情報
    Bucher Industries AG - Strategy, SWOT and Corporate Finance Report Summary Bucher Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • First Light Biosciences Inc:製品パイプライン分析
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for detection of healthcare associated infections. The company’s product include multipath analyzer. Its multipath analyzer detects resistant and sensitive staph …
  • GQ Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary GQ Life Sciences Inc (GQ Life Sciences), formerly GenomeQuest Inc, a subsidiary of Aptean Inc, is a life science information and search company that offers genomic software to search patents for biological sequences. The company provides lifequest, a patent search tool that provides a soluti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆